Finobrate 145mg Tablet contains Fenofibrate, a lipid-lowering agent primarily used to manage hypercholesterolemia and hypertriglyceridemia. Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), which increases the oxidation of fatty acids and reduces the production of triglycerides and very low-density lipoprotein (VLDL) cholesterol. This action helps to lower elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides, while often increasing high-density lipoprotein (HDL) cholesterol. Finobrate 145mg is typically prescribed to patients who have not achieved adequate lipid control through diet and lifestyle modifications alone. It is commonly used in individuals with mixed dyslipidemia or those at risk of cardiovascular disease due to abnormal lipid profiles. The tablet should be taken orally, usually once daily with food to enhance absorption and minimize gastrointestinal discomfort. Patients should adhere to their healthcare provider’s instructions and continue lifestyle interventions such as diet and exercise. Common side effects may include gastrointestinal symptoms, headache, and muscle pain, and regular monitoring of liver function and kidney function is recommended during therapy. Finobrate 145mg is not suitable for patients with severe liver or kidney impairment or gallbladder disease.